These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 32877038)

  • 1. [Policies vaccination against the Human papillomavirus infections in France and worldwide].
    Nicand É
    Rev Prat; 2020 Jan; 70(1):90-95. PubMed ID: 32877038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low vaccination coverage for human papillomavirus disease among young men who have sex with men, France, 2019.
    Ortu G; Barret AS; Danis K; Duchesne L; Levy-Bruhl D; Velter A
    Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness.
    Soe NN; Ong JJ; Ma X; Fairley CK; Latt PM; Jing J; Cheng F; Zhang L
    Hum Vaccin Immunother; 2018; 14(12):3010-3018. PubMed ID: 30024823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus vaccination coverage among men who have sex with men-National HIV Behavioral Surveillance, United States, 2017.
    McClung N; Burnett J; Wejnert C; Markowitz LE; Meites E;
    Vaccine; 2020 Nov; 38(47):7417-7421. PubMed ID: 33046266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Men having sex with men and the HPV vaccine in France: A low vaccine coverage that may be due to its infrequent proposal by physicians.
    Petit B; Epaulard O
    Vaccine; 2020 Feb; 38(9):2160-2165. PubMed ID: 32008880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus vaccination in general practice in France, three years after the implementation of a targeted vaccine recommendation based on age and sexual history.
    Thierry P; Lasserre A; Rossignol L; Kernéis S; Blaizeau F; Stheneur C; Blanchon T; Levy-Bruhl D; Hanslik T
    Hum Vaccin Immunother; 2016; 12(2):528-33. PubMed ID: 26309144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Qualitative Analysis of Young Sexual Minority Men's Perspectives on Human Papillomavirus Vaccination.
    Gerend MA; Madkins K; Crosby S; Korpak AK; Phillips GL; Bass M; Houlberg M; Mustanski B
    LGBT Health; 2019 Oct; 6(7):350-356. PubMed ID: 31556791
    [No Abstract]   [Full Text] [Related]  

  • 8. [Challenges in the implementation of HPV vaccination for cancer prevention].
    Rousseau S; Gaillot-de Saintignon J; Barret AS
    Rev Prat; 2019 May; 69(5):529-534. PubMed ID: 31626462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus vaccination coverage among young, gay, bisexual, and other men who have sex with men and transgender women - 3 U.S. cities, 2016-2018.
    Amiling R; Winer RL; Newcomb ME; Gorbach PM; Lin J; Crosby RA; Mustanski B; Markowitz LE; Meites E
    Hum Vaccin Immunother; 2021 Dec; 17(12):5407-5412. PubMed ID: 35213950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of HPV and attitudes towards HPV vaccination amongst men who have sex with men: A qualitative analysis.
    Nadarzynski T; Smith H; Richardson D; Pollard A; Llewellyn C
    Br J Health Psychol; 2017 May; 22(2):345-361. PubMed ID: 28191723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccines in Picardy, France: coverage and correlation with socioeconomic factors.
    Ganry O; Bernin-Mereau AS; Gignon M; Merlin-Brochard J; Schmit JL
    Rev Epidemiol Sante Publique; 2013 Oct; 61(5):447-54. PubMed ID: 24016739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
    Heard I; Tondeur L; Arowas L; Demazoin M; Falguières M; Parent Du Chatelet I;
    J Infect Dis; 2017 Mar; 215(5):757-763. PubMed ID: 28011911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda.
    Ngcobo NJ; Burnett RJ; Cooper S; Wiysonge CS
    S Afr Med J; 2018 Dec; 109(1):13-15. PubMed ID: 30606297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
    Lim ASE; Lim RBT
    Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour.
    Wolff E; Elfström KM; Haugen Cange H; Larsson S; Englund H; Sparén P; Roth A
    Vaccine; 2018 Aug; 36(34):5160-5165. PubMed ID: 30017146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus vaccine uptake among men in France: a national time series analysis for 2015-2018.
    Zeitoun JD; Duclos A; de Parades V; Lefèvre JH
    Hum Vaccin Immunother; 2020 Dec; 16(12):3119-3122. PubMed ID: 32401609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillomavirus and cancers: should we extend vaccination to boys in France?
    Abramowitz L; Descamps P; Denis F; Dommergues MA; Pradat P; St Guily JL; Judlin P
    J Public Health (Oxf); 2017 Dec; 39(4):e229-e234. PubMed ID: 27679660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.